Yong Rong (HK) Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Yong Rong (HK) Asset Management’s Portfolio RXRX Stock Details RXRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$8.77M	Buy
2021 Q4	–	Sell
2021 Q3	$8.68M	Buy